Autoantibodies in autoimmune liver diseases | Zendy

Sener Asli Gamze | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Autoantibodies in autoimmune liver diseases

Author(s) -

Sener Asli Gamze

Publication year - 2015

Publication title -

apmis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.909

H-Index - 88

eISSN - 1600-0463

pISSN - 0903-4641

DOI - 10.1111/apm.12442

Subject(s) - autoantibody , autoimmune hepatitis , primary biliary cirrhosis , medicine , immunology , hepatitis , primary sclerosing cholangitis , etiology , gamma globulin , cirrhosis , antibody , pathology , disease , gastroenterology

Autoimmune hepatitis is a chronic hepatitis of unknown etiology characterized by clinical, histological, and immunological features, generally including circulating autoantibodies and a high total serum and/or gamma globulin. Liver‐related autoantibodies are very significant for the correct diagnosis and classification of autoimmune liver diseases (AILD), namely autoimmune hepatitis types 1 and 2 (AIH‐1 and 2), primary biliary cirrhosis (PBC), and the sclerosing cholangitis types in adults and children. This article intends to review recent studies that investigate autoantibodies in autoimmune liver diseases from a microbiological perspective.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research